[Fibrin (ogen) Split products of nephropathies].
On healthy individuals fibrin(ogen) split products cannot be demonstrated in the blood. Catabolic products of fibrin and fibrinogen appear in the blood in case of general fibrinolysis, consumption coagulopathy with secondary fibrinolysis as well as local fibrin films with secondary fibrinolysis. The regular routine determination of fibrin(ogen) split products in serum or urine may indicate starting complications of many diseases. The appearance of these split products in case of renal affections indicates acute and active processes on the kidneys themselves; fibrin films appear in case of acute and chronic glomerulonephritis, casting-off crises on renal transplants, EPH gestosis, renal phlebothrombosis, hemolytic-uremic syndrom and occasionally urinary tract infections. The demonstration of fibrin(ogen) split products in serum or urine allows the following conclusions: a) acute and active process on the kidneys themselves; b) HMWS in urine indicate a fibrin film in the kidneys; c) an immediate beginning of an anticoagulation therapy; d) good possibilities to judge the therapeutic effect and by this the further progress of disease.
D004211:Disseminated Intravascular Coagulation / Q000097:blood; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D005342:Fibrinolysis; D005921:Glomerulonephritis / Q000378:metabolism; D006087:Graft vs Host Reaction / Q000378:metabolism; D006463:Hemolytic-Uremic Syndrome / Q000378:metabolism; D006801:Humans; D007122:Immunoelectrophoresis; D007223:Infant; D007674:Kidney Diseases / Q000097:blood / Q000378:metabolism* / Q000652:urine; D016030:Kidney Transplantation; D008970:Molecular Weight; D011225:Pre-Eclampsia / Q000378:metabolism; D011247:Pregnancy; D011379:Prognosis; D013927:Thrombosis / Q000378:metabolism; D014184:Transplantation, Homologous; D014552:Urinary Tract Infections / Q000378:metabolism
D005337:Fibrin; D005340:Fibrinogen
Fibrin (ogen)-Spaltprodukte bei Nierenerkrankungen